Silhouette

Devin E Eckhoff

Apoimmune, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
ApoFasL as a novel treatment for Type 1 Diabetes in Nonhuman Primates
Apoimmune, Inc.
Principal Investigator
HHS 1 $47.1K 09/01/11 08/31/13
ApoFasL as a novel treatment for Type 1 Diabetes in Nonhuman Primates
Apoimmune, Inc.
Principal Investigator
HHS 1 $400K 09/01/11 08/31/13
ApoFasL as a novel treatment for Type 1 Diabetes in Nonhuman Primates
Apoimmune, Inc.
Principal Investigator
HHS 1 $404K 09/05/10 08/31/11